Interim results from a clinical trial involving AstraZeneca’s Imfinzi (durvalumab) has delivered better efficacy when combined with neoadjuvant chemotherapy rather than chemotherapy alone. This has been observed in management of resectable non-small cell lung cancer. The phase 3 study, coded…
The National Medicines Regulatory Authority in Côte d’Ivoire, l’Autorité Ivorienne de Régulation Pharmaceutique (AIRP), in conjunction with the Marketing Authorization Holder, Medisource Laboratories, has decided to recall a batch of Finifat 500mg chewable tablets. Usage Finifat consists of vitamin C…
The National Medicines Regulatory Authority of Senegal, L’Agence sénégalaise de Règlementation pharmaceutique (L’ARP), has announced a temporary interruption in the supply of Pfizer’s Aldactazine (spironolactone/altizide) 25/15 mg and Aldactone (spironolactone), 50 mg and 75 mg tablets. Reason for unavailability L’ARP…
GSK announced “positive” results from a study comparing the efficacy of the 2-drug regimen dolutegravir/lamivudine (DTG/3TC) to the 3-drug regimen bictegravir/emtricitabine/tenofovir alafenamide fumarate (BIC/FTC/TAF) in managing virologically-suppressed adults living with HIV. Both regimens are administered as a single tablet per…
